炎症性肠病与脆弱性之间的关联:一个双样本的门德尔随机化研究
Jingyi Feng1, Xi Chen2, Wenjing Cai1
1School of Nursing, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Aging clinical and experimental research
|February 6, 2024
概括
炎症性肠病 (IBD) 可能会增加脆弱性风险,促使克罗恩病 (CD) 和性结肠炎 (UC) 患者的早期评估. 脆弱似乎不会导致IBD,但需要进一步的研究.
科学领域:
- 遗传学 遗传学 是一个
- 胃肠病学 胃肠病学
- 老年学是一门学科.
背景情况:
- 炎症性肠病 (IBD) 和虚弱之间存在关联,但因果关系尚不清楚.
- 门德尔随机化 (MR) 是一种可靠的方法,用于调查暴露和结果之间的因果关系.
- 本研究使用两样MR设计来探索IBD和脆弱性之间的关系.
研究的目的:
- 调查炎症性肠病 (IBD) 对虚弱的潜在因果影响.
- 检查虚弱对IBD的潜在因果作用,包括克罗恩病 (CD) 和性结肠炎 (UC).
主要方法:
- 进行了一种双向的双样本孟德尔随机化 (MR) 分析.
- 针对IBD (CD,UC) 和脆弱性的全基因组关联研究 (GWAS) 数据被用于选择仪器变量.
- 逆变量加权 (IVW) 分析是主要方法,并补充了灵敏度分析 (加权中位数,MR-Egger) 来评估异质性和多变性.
主要成果:
- 增加对脆弱性的遗传倾向显示出对IBD风险的因果关系 (OR: 1.015).
- 克罗恩病 (CD) 和性结肠炎 (UC) 均显示出对脆弱性倾向的增加 (CD OR: 1.018; UC OR: 1.016).
- 反向MR分析没有支持脆弱对IBD风险的因果关系.
结论:
- 炎症性肠病 (IBD),包括CD和UC,可能会增加患有脆弱性的风险.
- 建议对IBD患者进行早期脆弱性评估,以实现主动管理.
- 目前的证据不支持脆弱性在IBD发展中的因果作用,需要对潜在机制进行进一步研究.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
334
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
01:30Inflammatory Bowel Disease II: Crohn's Disease
244
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
244
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
186
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
186
01:17Chronic Bowel Disorders: Introduction
450
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
450
01:29Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
01:17Irritable Bowel Syndrome I: Introduction
276
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
276